This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Novartis Ag, Sandoz Pharmaceuticals Corp.. Active years: 1992-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gumligen, CH (1992 - 1994)
- Gümligen, CH (2015 - 2016)
Company Filing History:
Years Active: 1992-2016
Title: Werner Müller: A Pioneer in Pharmaceutical Innovations
Introduction
Werner Müller, based in Gümligen, Switzerland, is an accomplished inventor with a focus on pharmaceutical innovations. He holds two notable patents that showcase his expertise in the field of medicinal chemistry. His work contributes significantly to the advancement of pharmaceutical compositions and related processes, ultimately aiming to improve healthcare outcomes.
Latest Patents
One of Werner Müller’s key inventions is centered around 1-aza-bicyclo[3.3.1]nonanes. This patent pertains to 1-aza-bicycloalkyl derivatives of Formula (I). The invention outlines specific substituents and their roles in the production processes, pharmaceutical utilization, and the creation of pharmaceutical compositions comprising these compounds. The patent details intricate formulas, wherein substituents such as A and Y have precise functionalities, contributing to the effective application of these compounds in the pharmaceutical industry.
Career Highlights
Werner Müller is currently affiliated with Novartis AG, a leading global healthcare company. His role at Novartis allows him to engage in pioneering research aimed at developing innovative pharmaceutical solutions. Through his contributions, Müller strengthens the company's position in the pharmaceutical sector and brings groundbreaking innovations to the market.
Collaborations
Throughout his career, Werner has collaborated with esteemed colleagues, including Dominik Feuerbach and Bernard Lucien Roy. These partnerships enable a rich exchange of ideas and expertise, enhancing the development of novel therapeutics and encouraging innovative research in pharmaceuticals.
Conclusion
Werner Müller is a prominent figure in the realm of pharmaceutical inventions. His contributions, particularly in the area of 1-aza-bicyclo[3.3.1]nonanes, represent a significant advancement in medicinal chemistry. As he continues to work with Novartis AG and his talented colleagues, the impact of his innovations is sure to resonate within the healthcare industry for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile